Denosumab and sequential zoledronic acid to prevent bone loss and maintain bone mass after spinal cord injury

Project: Research project

Project Details

StatusActive
Effective start/end date8/1/247/31/26

Funding

  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (1R34AR082859-01A1)